REV-ERBα Regulates CYP7A1 Through Repression of Liver Receptor Homolog-1
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 46 (3) , 248-258
Abstract
REV-ERBα is a nuclear heme receptor (as known as a transcriptional repressor) that orchestrates circadian rhythms and cell metabolism. Here we investigate the role of LRH-1 in REV-ERBα regulation of CYP7A1 and cholesterol metabolism. We first characterized the tertiary amine GSK2945 as a highly specific Rev-erbα/REV-ERBα antagonist using cell-based assays and confirmed expression of Rev-erbα in mouse liver. GSK2945 treatment increased hepatic Cyp7a1 level and lowered plasma cholesterol in wild-type mice. Likewise, the compound increased the expression and microsomal activity of Cyp7a1 in hypercholesterolemic mice. This coincided with reduced plasma and liver cholesterol and enhanced production of bile acids. Increased levels of Cyp7a1/CYP7A1 were also found in mouse and human primary hepatocytes after GSK2945 treatment. In these experiments, we observed parallel increases in Lrh-1/LRH-1 (a known hepatic activator of Cyp7a1/CYP7A1) mRNA and protein. Luciferase reporter, mobility shift, and chromatin immunoprecipitation assays revealed that Lrh-1/LRH-1 was a direct Rev-erbα/REV-ERBα target gene. Furthermore, conditional deletion of Lrh-1 in the liver abrogated the regulatory effects of Rev-erbα on Cyp7a1 and cholesterol metabolism in mice. In conclusion, Rev-erbα regulates CYP7A1 and cholesterol metabolism through its repression of Lrh-1 receptor. Targeting REV-ERBα/Lrh-1 axis may represent a novel approach for management of cholesterol related diseases.Keywords
This publication has 41 references indexed in Scilit:
- Rev-erbα and Rev-erbβ coordinately protect the circadian clock and normal metabolic functionGenes & Development, 2012
- Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-βNature, 2012
- Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonistsNature, 2012
- Identification of SR8278, a Synthetic Antagonist of the Nuclear Heme Receptor REV-ERBACS Chemical Biology, 2010
- The Benzenesulfoamide T0901317 [N-(2,2,2-Trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] Is a Novel Retinoic Acid Receptor-Related Orphan Receptor-α/γ Inverse AgonistMolecular Pharmacology, 2010
- Nuclear Receptors Homo sapiens Rev-erbβ and Drosophila melanogaster E75 Are Thiolate-Ligated Heme Proteins Which Undergo Redox-Mediated Ligand Switching and Bind CO and NOBiochemistry, 2009
- Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC–MS/MSJournal of Chromatography B, 2008
- Regulation of Bile Acid Synthesis by the Nuclear Receptor Rev-erbαGastroenterology, 2008
- Identification of heme as the ligand for the orphan nuclear receptors REV-ERBα and REV-ERBβNature Structural & Molecular Biology, 2007
- The Orphan Nuclear Receptor REV-ERBα Controls Circadian Transcription within the Positive Limb of the Mammalian Circadian OscillatorCell, 2002